FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Lynn Hartmann

Research Profile

Disorders

Concepts & Ideas

Procedures

Anatomy

Breast

Physiology

Gene Expression Regulation, Neoplastic

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Michelle L Torres; Amy L Weaver; Phillip M Young; William A Cliby; Lynn C Hartmann; Aminah Jatoi; Kimberly R Kalli; Sanjeev Kumar; Carrie L Langstraat; Andrea Mariani
Nutritional status, CT body composition measures and survival in ovarian cancer.
L Joseph Melton; Terry M Therneau; Sara J Achenbach; Elizabeth J Atkinson; Lynn C Hartmann; Sundeep Khosla
Fracture risk in women with breast cancer: a population-based study.
Amy C Degnim; Marlene H Frost; Tanya L Hoskin; Derek Radisky; V Shane Pankratz; Celine M Vachon; Robert A Vierkant; Daniel W Visscher; Lynn C Hartmann
Histologic findings in normal breast tissues: comparison to reduction mammaplasty and benign breast disease tissues.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Lynn Hartmann (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Michelle L Torres; Amy L Weaver; Phillip M Young; William A Cliby; Lynn C Hartmann; Aminah Jatoi; Kimberly R Kalli; Sanjeev Kumar; Carrie L Langstraat; Andrea Mariani
Nutritional status, CT body composition measures and survival in ovarian cancer.
Gynecologic oncology 2013;129(3):548-53.
2012: L Joseph Melton; Terry M Therneau; Sara J Achenbach; Elizabeth J Atkinson; Lynn C Hartmann; Sundeep Khosla
Fracture risk in women with breast cancer: a population-based study.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2012;27(5):1196-205.
2012: Amy C Degnim; Marlene H Frost; Tanya L Hoskin; Derek Radisky; V Shane Pankratz; Celine M Vachon; Robert A Vierkant; Daniel W Visscher; Lynn C Hartmann
Histologic findings in normal breast tissues: comparison to reduction mammaplasty and benign breast disease tissues.
Breast cancer research and treatment 2012;133(1):169-77.
2012: Aminah Jatoi; Charles L Loprinzi; Dennis F Moore; Rex B Mowat; Jorge J Nieva; Paul J Novotny; Eduardo R Pajon; Rui Qin; Edward J Wos; Naftali Bechar; Lynn C Hartmann
A pilot study of long-acting octreotide for symptomatic malignant ascites.
Oncology 2012;82(6):315-20.
2011: Derek Radisky; Carol A Reynolds; Marta Santisteban; Thea D Tlsty; Robert A Vierkant; Daniel W Visscher; Hal K Berman; Marlene H Frost; Mona L Gauthier; V Shane Pankratz; Lynn C Hartmann
p16(INK4a) expression and breast cancer risk in women with atypical hyperplasia.
Cancer prevention research (Philadelphia, Pa.) 2011;4(12):1953-60.
2011: Daniel W Visscher; Lynn C Hartmann
Lobular neoplasia: how to manage with partial understanding.
Oncology (Williston Park, N.Y.) 2011;25(11):1066, 1068.
2011: Marlene H Frost; Lynn C Hartmann; Tanya L Hoskin; Joanne L Johnson; Amy C Degnim; Judy C Boughey
Contralateral prophylactic mastectomy: long-term consistency of satisfaction and adverse effects and the significance of informed decision-making, quality of life, and personality traits.
Annals of surgical oncology 2011;18(11):3110-6.
2011: Carol Reynolds; Nicole P Sandhu; Molly F Walsh; Jennifer A Davidson; Amy C Degnim; Katrina N Glazebrook; Lynn C Hartmann; James Jakub; Noralane M Lindor; Judy C Boughey
Prophylactic and therapeutic mastectomy in BRCA mutation carriers: can the nipple be preserved?
Annals of surgical oncology 2011;18(11):3102-9.
2011: S John Weroha; Ann L Oberg; Katie L Allen Ziegler; Shaker R Dakhilm; Kendrith M Rowland; Lynn C Hartmann; Dennis F Moore; Gary L Keeney; Prema P Peethambaram; Paul Haluska
Phase II trial of lapatinib and topotecan (LapTop) in patients with platinum-refractory/resistant ovarian and primary peritoneal carcinoma.
Gynecologic oncology 2011;122(1):116-20.
2011: Claudia C Preston; Ellen L Goode; Lynn C Hartmann; Kimberly R Kalli; Keith L Knutson
Immunity and immune suppression in human ovarian cancer.
Immunotherapy 2011;3(4):539-56.
2011: Fritcher Emily G Barr; Amy C Degnim; Lynn C Hartmann; Derek C Radisky; Judy C Boughey; Stephanie S Anderson; Robert A Vierkant; Marlene H Frost; Daniel W Visscher; Carol Reynolds
Estrogen receptor expression in atypical hyperplasia: lack of association with breast cancer.
Cancer prevention research (Philadelphia, Pa.) 2011;4(3):435-44.
2011: Takayo Ota; Amy C Clayton; Douglas M Minot; Viji Shridhar; Lynn C Hartmann; C Blake Gilks; Jeremy R Chien
Minichromosome maintenance protein 7 as a potential prognostic factor for progression-free survival in high-grade serous carcinomas of the ovary.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2011;24(2):277-87.
2011: R Rattan; S Giri; Lynn C Hartmann; Viji Shridhar
Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner.
Journal of cellular and molecular medicine 2011;15(1):166-78.
2010: Amy C Degnim; Marlene H Frost; Derek C Radisky; Stephanie S Anderson; Robert A Vierkant; Judy C Boughey; V Shane Pankratz; Karthik Ghosh; Lynn C Hartmann; Daniel W Visscher
Pseudoangiomatous stromal hyperplasia and breast cancer risk.
Annals of surgical oncology 2010;17(12):3269-77.
2010: Judy C Boughey; Tanya L Hoskin; Amy C Degnim; Thomas A Sellers; Joanne L Johnson; Melanie J Kasner; Lynn C Hartmann; Marlene H Frost
Contralateral prophylactic mastectomy is associated with a survival advantage in high-risk women with a personal history of breast cancer.
Annals of surgical oncology 2010;17(10):2702-9.
2010: Karthik Ghosh; Lynn C Hartmann; Carol Reynolds; Daniel W Visscher; Kathleen R Brandt; Robert A Vierkant; Christopher G Scott; Derek Radisky; Thomas A Sellers; V Shane Pankratz; Celine M Vachon
Association between mammographic density and age-related lobular involution of the breast.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(13):2207-12.
2010: Mark R Litzow; Prema P Peethambaram; Stephanie L Safgren; Gary L Keeney; Stephen M Ansell; Angela Dispenzieri; Michelle A Elliott; Dennis A Gastineau; Morie A Gertz; David J Inwards; Martha Q Lacy; Ivana N M Micallef; Luis F Porrata; W L Lingle; Lynn C Hartmann; M H Frost; B A Barrette; Harry J Long; Vera J Suman; Joel M Reid; Matthew M Ames; S H Kaufmann
Phase I trial of autologous hematopoietic SCT with escalating doses of topotecan combined with CY and carboplatin in patients with relapsed or persistent ovarian or primary peritoneal carcinoma.
Bone marrow transplantation 2010;45(3):490-7.
2010: Ellen L Goode; Matthew J Maurer; Thomas A Sellers; Catherine M Phelan; Kimberly R Kalli; Brooke L Fridley; Robert A Vierkant; Sebastian M Armasu; Kristin L White; Gary L Keeney; William A Cliby; David N Rider; Linda E Kelemen; Monica B Jones; Prema P Peethambaram; Johnathan M Lancaster; Janet E Olson; Joellen M Schildkraut; Julie M Cunningham; Lynn C Hartmann
Inherited determinants of ovarian cancer survival.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(3):995-1007.
2010: Lavakumar Karyampudi; Courtney Formicola; Courtney L Erskine; Matthew J Maurer; James N Ingle; Christopher J Krco; Peter J Wettstein; Kimberly R Kalli; John D Fikes; Melanie Beebe; Lynn C Hartmann; Mary L Disis; Soldano Ferrone; Glenn Ishioka; Keith L Knutson
A degenerate HLA-DR epitope pool of HER-2/neu reveals a novel in vivo immunodominant epitope, HER-2/neu88-102.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(3):825-34.
2010: Evanthia C Galanis; Lynn C Hartmann; William A Cliby; Harry J Long; Prema P Peethambaram; Brigitte A Barrette; Judith S Kaur; Paul J Haluska; Ileana Aderca; Paula J Zollman; Jeff A Sloan; Gary L Keeney; Pamela J Atherton; Karl C Podratz; Sean C Dowdy; C Robert Stanhope; Timothy O Wilson; Mark J Federspiel; Kah-Whye Peng; Stephen J Russell
Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer.
Cancer research 2010;70(3):875-82.
2010: Abraham Peedicayil; Robert A Vierkant; Lynn C Hartmann; Brooke L Fridley; Zachary S Fredericksen; Kristin L White; Elaine A Elliott; Catherine M Phelan; Ya-Yu Tsai; Andrew Berchuck; Edwin S Iversen; Fergus J Couch; Prema Peethamabaran; Melissa C Larson; Kimberly R Kalli; Matthew L Kosel; Viji Shridhar; David N Rider; Mark Liebow; Julie M Cunningham; Joellen M Schildkraut; Thomas A Sellers; Ellen L Goode
Risk of ovarian cancer and inherited variants in relapse-associated genes.
PloS one 2010;5(1):e8884.
2010: Lavakumar Karyampudi; Christopher J Krco; Kimberly R Kalli; Courtney L Erskine; Lynn C Hartmann; Karin Goodman; James N Ingle; Matthew J Maurer; Aziza Nassar; Chao Yu; Mary L Disis; Peter J Wettstein; John D Fikes; Melanie Beebe; Glenn Ishioka; Keith L Knutson
Identification of a broad coverage HLA-DR degenerate epitope pool derived from carcinoembryonic antigen.
Cancer immunology, immunotherapy : CII 2010;59(1):161-71.
2009: Robert A Vierkant; Lynn C Hartmann; V Shane Pankratz; Stephanie S Anderson; Derek Radisky; Marlene H Frost; Celine M Vachon; Karthik Ghosh; Tammy J Distad; Amy C Degnim; Carol A Reynolds
Lobular involution: localized phenomenon or field effect?
Breast cancer research and treatment 2009;117(1):193-6.
2009: Clive S Grant; James N Ingle; Vera J Suman; Daniel A Dumesic; D Lawrence Wickerham; Richard D Gelber; Patrick J Flynn; Lorna M Weir; Mattia Intra; Wayne O Jones; Edith A Perez; Lynn C Hartmann
Menstrual cycle and surgical treatment of breast cancer: findings from the NCCTG N9431 study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(22):3620-6.
2009: Abraham Peedicayil; Robert A Vierkant; Viji Shridhar; Joellen M Schildkraut; Sebastian Armasu; Lynn C Hartmann; Brooke L Fridley; Julie M Cunningham; Catherine M Phelan; Thomas A Sellers; Ellen L Goode
Polymorphisms in TCEAL7 and risk of epithelial ovarian cancer.
Gynecologic oncology 2009;114(2):260-4.
2009: Jeremy Chien; Jian-Bing Fan; Debra A Bell; Craig April; Brandy Klotzle; Takayo Ota; Wilma L Lingle; Jesus Gonzalez Bosquet; Viji Shridhar; Lynn C Hartmann
Analysis of gene expression in stage I serous tumors identifies critical pathways altered in ovarian cancer.
Gynecologic oncology 2009;114(1):3-11.
2009: Derek Radisky; Lynn C Hartmann
Mammary involution and breast cancer risk: transgenic models and clinical studies.
Journal of mammary gland biology and neoplasia 2009;14(2):181-91.
2009: Marta Santisteban; Jennifer M Reiman; Michael K Asiedu; Marshall D Behrens; Aziza Nassar; Kimberly R Kalli; Paul Haluska; James N Ingle; Lynn C Hartmann; Masoud H Manjili; Derek Radisky; Soldano Ferrone; Keith L Knutson
Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells.
Cancer research 2009;69(7):2887-95.
2009: Eati Basal; Guiti Z Eghbali-Fatourechi; Kimberly R Kalli; Lynn C Hartmann; Karin M Goodman; Ellen L Goode; Barton A. Kamen; Philip S Low; Keith L Knutson
Functional folate receptor alpha is elevated in the blood of ovarian cancer patients.
PloS one 2009;4(7):e6292.
2009: Kristin L White; Robert A Vierkant; Catherine M Phelan; Brooke L Fridley; Stephanie Anderson; Keith L Knutson; Joellen M Schildkraut; Julie M Cunningham; Linda E Kelemen; V Shane Pankratz; David N Rider; Mark Liebow; Lynn C Hartmann; Thomas A Sellers; Ellen L Goode
Polymorphisms in NF-kappaB inhibitors and risk of epithelial ovarian cancer.
BMC cancer 2009;9():170.
2008: V Shane Pankratz; Lynn C Hartmann; Amy C Degnim; Robert A Vierkant; Karthik Ghosh; Celine M Vachon; Marlene H Frost; Shaun D Maloney; Carol Reynolds; Judy C Boughey
Assessment of the accuracy of the Gail model in women with atypical hyperplasia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(33):5374-9.
2008: Kimberly R Kalli; Christopher J Krco; Lynn C Hartmann; Karin Goodman; Matthew J Maurer; Chao Yu; Elliot M Johnson; Courtney L Erskine; Mary L Disis; Peter J Wettstein; John D Fikes; Melanie Beebe; Glenn Ishioka; Keith L Knutson
An HLA-DR-degenerate epitope pool detects insulin-like growth factor binding protein 2-specific immunity in patients with cancer.
Cancer research 2008;68(12):4893-901.
2008: Heidi McKean; Sherry Looker; Lynn C Hartmann; Suzanne R Hayman; Judith S Kaur; Robert R McWilliams; Prema P Peethambaram; Jean F Stahl; Aminah Jatoi
Are cancer survivors/patients knowledgeable about osteoporosis? Results from a survey of 285 chemotherapy-treated cancer patients and their companions.
Journal of nutrition education and behavior 2008;40(3):144-8.
2008: Jena C Berg; Daniel W Visscher; Robert A Vierkant; V Shane Pankratz; Shaun D Maloney; Jason T Lewis; Marlene H Frost; Karthik Ghosh; Amy C Degnim; Kathleen R Brandt; Celine M Vachon; Carol A Reynolds; Lynn C Hartmann
Breast cancer risk in women with radial scars in benign breast biopsies.
Breast cancer research and treatment 2008;108(2):167-74.
2008: Kimberly R Kalli; Ann L Oberg; Gary L Keeney; Teresa J H Christianson; Philip S Low; Keith L Knutson; Lynn C Hartmann
Folate receptor alpha as a tumor target in epithelial ovarian cancer.
Gynecologic oncology 2008;108(3):619-26.
2008: Aditya Bardia; Celine M Vachon; Janet E Olson; Robert A Vierkant; Alice H Wang; Lynn C Hartmann; Thomas A Sellers; James Cerhan
Relative weight at age 12 and risk of postmenopausal breast cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008;17(2):374-8.
2007: Jeremy R Chien; Giacomo Aletti; Debra A Bell; Gary L Keeney; Viji Shridhar; Lynn C Hartmann
Molecular pathogenesis and therapeutic targets in epithelial ovarian cancer.
Journal of cellular biochemistry 2007;102(5):1117-29.
2007: Lynn C Hartmann; Gary L Keeney; Wilma L Lingle; Teresa J H Christianson; Bindu Varghese; David Hillman; Ann L Oberg; Philip S Low
Folate receptor overexpression is associated with poor outcome in breast cancer.
International journal of cancer. Journal international du cancer 2007;121(5):938-42.
2007: Amy C Degnim; Daniel W Visscher; Hal K Berman; Marlene H Frost; Thomas A Sellers; Robert A Vierkant; Shaun D Maloney; V Shane Pankratz; Piet C de Groen; Wilma L Lingle; Karthik Ghosh; Lois Penheiter; Thea D Tlsty; Joseph L Melton; Carol A Reynolds; Lynn C Hartmann
Stratification of breast cancer risk in women with atypia: a Mayo cohort study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(19):2671-7.
2007: Giacomo Aletti; Mary M Gallenberg; William A Cliby; Aminah Jatoi; Lynn C Hartmann
Current management strategies for ovarian cancer.
Mayo Clinic proceedings. Mayo Clinic 2007;82(6):751-70.
2006: Aditya Bardia; Lynn C Hartmann; Celine M Vachon; Robert A Vierkant; Alice H Wang; Janet E Olson; Thomas A Sellers; James Cerhan
Recreational physical activity and risk of postmenopausal breast cancer based on hormone receptor status.
Archives of internal medicine 2006;166(22):2478-83.
2006: Tia R Milanese; Lynn C Hartmann; Thomas A Sellers; Marlene H Frost; Robert A Vierkant; Shaun D Maloney; V Shane Pankratz; Amy C Degnim; Celine M Vachon; Carol A Reynolds; Romayne A Thompson; Joseph L Melton; Ellen L Goode; Daniel W Visscher
Age-related lobular involution and risk of breast cancer.
Journal of the National Cancer Institute 2006;98(22):1600-7.
2006: Keith L Knutson; Christopher J Krco; Courtney L Erskine; Karin Goodman; Linda E Kelemen; Peter J Wettstein; Philip S Low; Lynn C Hartmann; Kimberly R Kalli
T-cell immunity to the folate receptor alpha is prevalent in women with breast or ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(26):4254-61.
2006: Jeremy Chien; Giacomo Aletti; Alfonso Baldi; Vincenzo Catalano; Pietro Muretto; Gary L Keeney; Kimberly R Kalli; Julie Staub; Michael Ehrmann; William A Cliby; Yean Kit Lee; Keith C Bible; Lynn C Hartmann; Scott H Kaufmann; Viji Shridhar
Serine protease HtrA1 modulates chemotherapy-induced cytotoxicity.
The Journal of clinical investigation 2006;116(7):1994-2004.
2006: Jason T Lewis; Lynn C Hartmann; Robert A Vierkant; Shaun D Maloney; V Shane Pankratz; Teresa M Allers; Marlene H Frost; Daniel W Visscher
An analysis of breast cancer risk in women with single, multiple, and atypical papilloma.
The American journal of surgical pathology 2006;30(6):665-72.
2005: Frank De Smet; Nathalie Pochet; Bart De Moor; Toon Van Gorp; Dirk Timmerman; Ignace Vergote; Lynn C Hartmann; Andrew I Damokosh; Sebastian Hoersch
Independent test set performance in the prediction of early relapse in ovarian cancer with gene expression profiles.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(21):7958-9; author reply 7959.
2005: Marlene H Frost; Jeffrey M Slezak; Nho V Tran; Constance I Williams; Joanne L Johnson; John E Woods; Paul M Petty; John H Donohue; Clive S Grant; Jeff A Sloan; Thomas A Sellers; Lynn C Hartmann
Satisfaction after contralateral prophylactic mastectomy: the significance of mastectomy type, reconstructive complications, and body appearance.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(31):7849-56.
2005: Aminah Jatoi; Karin F Giordano; Phuong L Nguyen; Jeff Sloan; Lynn C Hartmann
Targeting and palliating malignant ascites: an overview of an upcoming clinical trial from the north central cancer treatment group.
Supportive cancer therapy 2005;3(1):59-62.
2005: Jeremy Chien; Julie Staub; Rajeswari Avula; Heyu Zhang; Wanguo Liu; Lynn C Hartmann; Scott H Kaufmann; David I Smith; Viji Shridhar
Epigenetic silencing of TCEAL7 (Bex4) in ovarian cancer.
Oncogene 2005;24(32):5089-100.
2005: Karthik Ghosh; Joseph L Melton; Vera J Suman; Clive S Grant; Sylvester Sterioff; Kathy R Brandt; Charles Branch; Thomas A Sellers; Lynn C Hartmann
Breast biopsy utilization: a population-based study.
Archives of internal medicine 2005;165(14):1593-8.
2005: Lynn C Hartmann; Thomas A Sellers; Marlene H Frost; Wilma L Lingle; Amy C Degnim; Karthik Ghosh; Robert A Vierkant; Shaun D Maloney; V Shane Pankratz; David W Hillman; Vera J Suman; Jo Johnson; Cassann Blake; Thea D Tlsty; Celine M Vachon; Joseph L Melton; Daniel W Visscher
Benign breast disease and the risk of breast cancer.
The New England journal of medicine 2005;353(3):229-37.
2005: Peter J Tebben; Kimberly R Kalli; William A Cliby; Lynn C Hartmann; Joseph P Grande; Ravinder J Singh; Rajiv Kumar
Elevated fibroblast growth factor 23 in women with malignant ovarian tumors.
Mayo Clinic proceedings. Mayo Clinic 2005;80(6):745-51.
2005: Lynn C Hartmann; Karen H Lu; Gerald P Linette; William A Cliby; Kimberly R Kalli; David M Gershenson; Robert C Bast; James Stec; Natalia Iartchouk; David I Smith; Jeffrey S Ross; Sebastian Hoersch; Viji Shridhar; James Lillie; Scott H Kaufmann; Edwin A Clark; Andrew I Damokosh
Gene expression profiles predict early relapse in ovarian cancer after platinum-paclitaxel chemotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(6):2149-55.
2004: Sean C Dowdy; Michael Stefanek; Lynn C Hartmann
Surgical risk reduction: prophylactic salpingo-oophorectomy and prophylactic mastectomy.
American journal of obstetrics and gynecology 2004;191(4):1113-23.
2004: Camilo Adem; Cheryl L Soderberg; Kari Hafner; Carol Reynolds; Jeffrey M Slezak; Colleen S Sinclair; Thomas A Sellers; Daniel J Schaid; Fergus J. Couch; Lynn C Hartmann; Robert B Jenkins
ERBB2, TBX2, RPS6KB1, and MYC alterations in breast tissues of BRCA1 and BRCA2 mutation carriers.
Genes, chromosomes & cancer 2004;41(1):1-11.
2004: Aminah Jatoi; Karl C Podratz; Paula Gill; Lynn C Hartmann
Pathophysiology and palliation of inoperable bowel obstruction in patients with ovarian cancer.
The journal of supportive oncology 2004;2(4):323-34; discussion 334-7.
2004: Janet E Olson; Thomas A Sellers; Stephen J Iturria; Lynn C Hartmann
Bilateral oophorectomy and breast cancer risk reduction among women with a family history.
Cancer detection and prevention 2004;28(5):357-60.
2003: Sean C Dowdy; Costas L Constantinou; Lynn C Hartmann; Gary L Keeney; Vera J Suman; David W Hillman; Karl C Podratz
Long-term follow-up of women with ovarian cancer after positive second-look laparotomy.
Gynecologic oncology 2003;91(3):563-8.
2003: Kimberly R Kalli; Kathryn E Devine; Myles C Cabot; Christina R Arnt; Michael P Heldebrant; Phyllis A Svingen; Charles Erlichman; Lynn C Hartmann; Cheryl A Conover; Scott H Kaufmann
Heterogeneous role of caspase-8 in fenretinide-induced apoptosis in epithelial ovarian carcinoma cell lines.
Molecular pharmacology 2003;64(6):1434-43.
2003: Camilo Adem; Cheryl L Soderberg; Julie M Cunningham; Carol Reynolds; Thomas J Sebo; Stephen N Thibodeau; Lynn C Hartmann; Robert B Jenkins
Microsatellite instability in hereditary and sporadic breast cancers.
International journal of cancer. Journal international du cancer 2003;107(4):580-2.
2003: Sara M Zion; Jeffrey M Slezak; Thomas A Sellers; John E Woods; Phillip G Arnold; Paul M Petty; John H Donohue; Marlene H Frost; Daniel J Schaid; Lynn C Hartmann
Reoperations after prophylactic mastectomy with or without implant reconstruction.
Cancer 2003;98(10):2152-60.
2003: Julie A Ponto; Marlene H Frost; Romayne Thompson; Teresa Allers; Tracy Reed-Will; Katherine M Zahasky; Kay B Thiemann; Jane H Chelf; Mary E Johnson; Sylvester Sterioff; Joseph Rubin; Lynn C Hartmann
Stories of breast cancer through art.
Oncology nursing forum 2003;30(6):1007-13.
2003: Janos L Tanyi; Yutaka Hasegawa; Ruth Lapushin; Andrew J Morris; Judith K Wolf; Andrew Berchuck; Karen Lu; David I Smith; Kimberly R Kalli; Lynn C Hartmann; Karen McCune; David Fishman; Russell R Broaddus; Kwai Wa Cheng; E Neely Atkinson; Jose-Miguel Yamal; Robert C Bast; Edward Felix; Robert A Newman; Gordon B Mills
Role of decreased levels of lipid phosphate phosphatase-1 in accumulation of lysophosphatidic acid in ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(10 Pt 1):3534-45.
2003: Prema P Peethambaram; William A Cliby; Gregory Lubiniecki; Amy C Clayton; Patrick C Roche; Stephen J Iturria; Lynn C Hartmann; Ingegerd Hellström; Scott E Strome
Her-2/neu expression in ovarian cancer: pre- and postexposure to platinum chemotherapy.
Gynecologic oncology 2003;89(1):99-104.
2003: Lawrence B. Riggs; Lynn C Hartmann
Selective estrogen-receptor modulators -- mechanisms of action and application to clinical practice.
The New England journal of medicine 2003;348(7):618-29.
2003: Camilo Adem; Carol Reynolds; Cheryl L Soderberg; Jeffrey M Slezak; Shannon K McDonnell; Thomas J Sebo; Daniel J Schaid; Jeffrey L Myers; Thomas A Sellers; Lynn C Hartmann; Robert B Jenkins
Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers.
Cancer 2003;97(1):1-11.
2002: Harry J Long; Sandra Rayson; Karl C Podratz; Samir Abu-Ghazaleh; Vera J Suman; Lynn C Hartmann; Ralph Levitt; Suresh Nair; Alan K Hatfield; James A Knost
Long-term survival of patients with advanced/recurrent carcinoma of cervix and vagina after neoadjuvant treatment with methotrexate, vinblastine, doxorubicin, and cisplatin with or without the addition of molgramostim, and review of the literature.
American journal of clinical oncology 2002;25(6):547-51.
2002: Kah-Whye Peng; Cynthia J Teneyck; Evanthia C Galanis; Kimberly R Kalli; Lynn C Hartmann; stephen russell
Intraperitoneal therapy of ovarian cancer using an engineered measles virus.
Cancer research 2002;62(16):4656-62.
2002: Sean C Dowdy; Cecelia H Boardman; Timothy O Wilson; Karl C Podratz; Lynn C Hartmann; Harry J Long
Multimodal therapy including neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) for stage IIB to IV cervical cancer.
American journal of obstetrics and gynecology 2002;186(6):1167-73.
2001: Lynn C Hartmann; Thomas A Sellers; Daniel J Schaid; T S Frank; Cheryl L Soderberg; DL Sitta; Marlene H Frost; Clive S Grant; John H Donohue; John E Woods; Shannon K McDonnell; Cate Walsh Vockley; Amie M Deffenbaugh; Fergus J. Couch; Robert B Jenkins
Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers.
Journal of the National Cancer Institute 2001;93(21):1633-7.
2001: Shannon K McDonnell; Daniel J Schaid; Jeffrey L Myers; Clive S Grant; John H Donohue; John E Woods; Marlene H Frost; Joanne L Johnson; DL Sitta; Jeffrey M Slezak; TB Crotty; Robert B Jenkins; Thomas A Sellers; Lynn C Hartmann
Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(19):3938-43.
2001: Bobbie S Gostout; Lynn C Hartmann; Vera J Suman; Nancy E Fay; J A Jefferies; Roscoe F Morton; Thomas A Gaffey; Gist Henry Farr; Loren K Tschetter; Samir Abu-Ghazaleh; Mary M Gallenberg; Alan K Hatfield
A randomized trial of interferon-alpha in cervical dysplasia.
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2001;74(2):207-10.
2001: Viji Shridhar; John Lee; Ajay Pandita; Stephen J Iturria; Rajeswari Avula; Julie Staub; M Morrissey; E Calhoun; A Sen; Kimberly R Kalli; Gary L Keeney; P Roche; William A Cliby; K Lu; Rosemarie Schmandt; Gordon B Mills; Robert C Bast; C David James; Fergus J. Couch; Lynn C Hartmann; Jim Lillie; David I Smith
Genetic analysis of early- versus late-stage ovarian tumors.
Cancer research 2001;61(15):5895-904.
2001: Viji Shridhar; K C Bible; Julie Staub; Rajeswari Avula; Y K Lee; Kimberly R Kalli; H Huang; Lynn C Hartmann; Scott H Kaufmann; David I Smith
Loss of expression of a new member of the DNAJ protein family confers resistance to chemotherapeutic agents used in the treatment of ovarian cancer.
Cancer research 2001;61(10):4258-65.
2000: Edith A Perez; David W Hillman; Philip J Stella; James E Krook; Lynn C Hartmann; Tom R Fitch; Alan K Hatfield; James A Mailliard; Suresh Nair; Carl G Kardinal; James N Ingle
A phase II study of paclitaxel plus carboplatin as first-line chemotherapy for women with metastatic breast carcinoma.
Cancer 2000;88(1):124-31.
1999: S V Rajkumar; Lynn C Hartmann
Screening mammography in women aged 40-49 years.
Medicine 1999;78(6):410-6.
1999: James N Ingle; Vera J Suman; Carl G Kardinal; James E Krook; James A Mailliard; Michael H Veeder; Charles L Loprinzi; Robert J Dalton; Lynn C Hartmann; C A Conover; M N Pollak
A randomized trial of tamoxifen alone or combined with octreotide in the treatment of women with metastatic breast carcinoma.
Cancer 1999;85(6):1284-92.
1999: Prema P Peethambaram; James N Ingle; Vera J Suman; Lynn C Hartmann; Charles L Loprinzi
Randomized trial of diethylstilbestrol vs. tamoxifen in postmenopausal women with metastatic breast cancer. An updated analysis.
Breast cancer research and treatment 1999;54(2):117-22.
1999: Lynn C Hartmann; Daniel J Schaid; John E Woods; T P Crotty; Jeffrey L Myers; Philip G Arnold; Paul M Petty; Thomas A Sellers; Joanne L Johnson; Shannon K McDonnell; Marlene H Frost; Robert B Jenkins
Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer.
The New England journal of medicine 1999;340(2):77-84.
1998: Cheryl A Conover; Lynn C Hartmann; S Bradley; P Stalboerger; G G Klee; Kimberly R Kalli; R B Jenkins
Biological characterization of human epithelial ovarian carcinoma cells in primary culture: the insulin-like growth factor system.
Experimental cell research 1998;238(2):439-49.
1997: James N Ingle; Patricia A. Johnson; Vera J Suman; JB Gerstner; James A Mailliard; John K Camoriano; Dean H Gesme; Charles L Loprinzi; Alan K Hatfield; Lynn C Hartmann
A randomized phase II trial of two dosage levels of letrozole as third-line hormonal therapy for women with metastatic breast carcinoma.
Cancer 1997;80(2):218-24.
1997: Lynn C Hartmann; Loren K Tschetter; T M Habermann; Larry P Ebbert; P S Johnson; James A Mailliard; Ralph Levitt; Vera J Suman; Thomas E Witzig; HS Wieand; Langdon L Miller; CG Moertel
Granulocyte colony-stimulating factor in severe chemotherapy-induced afebrile neutropenia.
The New England journal of medicine 1997;336(25):1776-80.
1996: Diane L Persons; R A Robinson; P H Hsu; S A Seelig; Thomas J Borell; Lynn C Hartmann; Robert B Jenkins
Chromosome-specific aneusomy in carcinoma of the breast.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(5):883-8.
1995: James N Ingle; James E Krook; James A Mailliard; Lynn C Hartmann; H S Wieand
Evaluation of ifosfamide plus mesna as first-line chemotherapy in women with metastatic breast cancer.
American journal of clinical oncology 1995;18(6):498-501.
1995: M Q Lacy; Lynn C Hartmann; Gary L Keeney; S C Cha; H S Wieand; Karl C Podratz; Patrick C Roche
c-erbB-2 and p53 expression in fallopian tube carcinoma.
Cancer 1995;75(12):2891-6.
1994: Lynn C Hartmann; James N Ingle; L E Wold; Gist Henry Farr; J P Grill; J Q Su; Nita Maihle; James E Krook; Thomas E Witzig; Patrick C Roche
Prognostic value of c-erbB2 overexpression in axillary lymph node positive breast cancer. Results from a randomized adjuvant treatment protocol.
Cancer 1994;74(11):2956-63.
1994: Diane L Persons; Lynn C Hartmann; J F Herath; Gary L Keeney; Robert B Jenkins
Fluorescence in situ hybridization analysis of trisomy 12 in ovarian tumors.
American journal of clinical pathology 1994;102(6):775-9.
1994: L D Erickson; Lynn C Hartmann; J Q Su; S N Nielsen; D M Pfeifel; Richard M Goldberg; Ralph Levitt; C Robert Stanhope
Cyclophosphamide, cisplatin, and leuprolide acetate in patients with debulked stage III or IV ovarian carcinoma.
Gynecologic oncology 1994;54(2):196-200.
1994: James N Ingle; J F Foley; James A Mailliard; James E Krook; Lynn C Hartmann; S H Jung; Michael H Veeder; Dean H Gesme; Alan K Hatfield; Richard M Goldberg
Randomized trial of cyclophosphamide, methotrexate, and 5-fluorouracil with or without estrogenic recruitment in women with metastatic breast cancer.
Cancer 1994;73(9):2337-43.
1994: Lynn C Hartmann; Karl C Podratz; Gary L Keeney; N A Kamel; J H Edmonson; J P Grill; J Q Su; J A Katzmann; Patrick C Roche
Prognostic significance of p53 immunostaining in epithelial ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(1):64-9.
1993: M K Dodson; Lynn C Hartmann; William A Cliby; K A DeLacey; Gary L Keeney; S R Ritland; J Q Su; Karl C Podratz; Robert B Jenkins
Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas.
Cancer research 1993;53(19):4456-60.
1993: Diane L Persons; Lynn C Hartmann; J F Herath; Thomas J Borell; William A Cliby; Gary L Keeney; Robert B Jenkins
Interphase molecular cytogenetic analysis of epithelial ovarian carcinomas.
The American journal of pathology 1993;142(3):733-41.
1992: J H Edmonson; Lynn C Hartmann; H J Long; G Colon-Otero; Tom R Fitch; J A Jefferies; T A Braich; W J Maples
Granulocyte-macrophage colony-stimulating factor. Preliminary observations on the influences of dose, schedule, and route of administration in patients receiving cyclophosphamide and carboplatin.
Cancer 1992;70(10):2529-39.
1992: M D Hauge; H J Long; Lynn C Hartmann; J H Edmonson; M J Webb; J Su
Phase II trial of intravenous hexamethylmelamine in patients with advanced ovarian cancer.
Investigational new drugs 1992;10(4):299-301.
1992: Lynn C Hartmann; Thomas J Sebo; N A Kamel; Karl C Podratz; S S Cha; H S Wieand; Gary L Keeney; Patrick C Roche
Proliferating cell nuclear antigen in epithelial ovarian cancer: relation to results at second-look laparotomy and survival.
Gynecologic oncology 1992;47(2):191-5.
1990: Lynn C Hartmann; S Frytak; Ronald L Richardson; D T Coles; R E Cupps
Life-threatening bleomycin pulmonary toxicity with ultimate reversibility.
Chest 1990;98(2):497-9.
1989: Lynn C Hartmann; G F Oliver; R K Winkelmann; T V Colby; T M Sundt; Brian Patrick O'Neill
Blue nevus and nevus of Ota associated with dural melanoma.
Cancer 1989;64(1):182-6.